Withaferin A and Celastrol Overwhelm Proteostasis
- PMID: 38203539
- PMCID: PMC10779417
- DOI: 10.3390/ijms25010367
Withaferin A and Celastrol Overwhelm Proteostasis
Abstract
Withaferin A (WA) and celastrol (CEL) are major bioactive components of plants that have been widely employed in traditional medicine. The pleiotropic activities of plant preparations and the isolated compounds in vitro and in vivo have been documented in hundreds of studies. Both WA and CEL were shown to have anticancer activity. Although WA and CEL belong to different chemical classes, our synthesis of the available information suggests that the compounds share basic mechanisms of action. Both WA and CEL bind covalently to numerous proteins, causing the partial unfolding of some of these proteins and of many bystander proteins. The resulting proteotoxic stress, when excessive, leads to cell death. Both WA and CEL trigger the activation of the unfolded protein response (UPR) which, if the proteotoxic stress persists, results in apoptosis mediated by the PERK/eIF-2/ATF4/CHOP pathway or another UPR-dependent pathway. Other mechanisms of cell death may play contributory or even dominant roles depending on cell type. As shown in a proteomic study with WA, the compounds appear to function largely as electrophilic reactants, indiscriminately modifying reachable nucleophilic amino acid side chains of proteins. However, a remarkable degree of target specificity is imparted by the cellular context.
Keywords: IHSF; Withaferin A; celastrol; protein aggregation; protein unfolding; proteostasis.
Conflict of interest statement
R.V. is the founder and CEO of HSF Pharmaceuticals SA, a company focusing on research and early development. N.V. declares no conflicts. HSF Pharmaceuticals SA and the Foundation for Biomedical Research of the La Paz University Hospital have proprietary interests in IHSFs.
Figures
Similar articles
-
Proteomic characterization of Withaferin A-targeted protein networks for the treatment of monoclonal myeloma gammopathies.J Proteomics. 2018 May 15;179:17-29. doi: 10.1016/j.jprot.2018.02.013. Epub 2018 Feb 13. J Proteomics. 2018. PMID: 29448055
-
Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications.Pharmaceuticals (Basel). 2023 Apr 19;16(4):616. doi: 10.3390/ph16040616. Pharmaceuticals (Basel). 2023. PMID: 37111374 Free PMC article.
-
Different effects of 4β-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells.Phytomedicine. 2019 Feb;53:213-222. doi: 10.1016/j.phymed.2018.09.017. Epub 2018 Sep 5. Phytomedicine. 2019. PMID: 30668401
-
Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera.Environ Sci Pollut Res Int. 2020 Jul;27(21):26025-26035. doi: 10.1007/s11356-020-09028-0. Epub 2020 May 13. Environ Sci Pollut Res Int. 2020. PMID: 32405942 Review.
-
A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.Cancer Prev Res (Phila). 2020 Sep;13(9):721-734. doi: 10.1158/1940-6207.CAPR-20-0259. Epub 2020 Jul 29. Cancer Prev Res (Phila). 2020. PMID: 32727824 Free PMC article. Review.
References
-
- Kumar S., Mathew S.O., Aharwal R.P., Tulli H.S., Mohan C.D., Sethi G., Ahn K.-S., Sandhu S.S., Webber K., Bishayee A. Withaferin A: A pleiotropic anticancer agent from the Indian medicinal plant Withania somnifera (L.) Dunal. Pharmaceuticals. 2023;16:160. doi: 10.3390/ph16020160. - DOI - PMC - PubMed
-
- Singh G., Sharma P., Dudhe R., Singh S. Biological activities of Withania somnifera. Ann. Biol. Res. 2010;1:56–63.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials